Literature DB >> 18984417

Treatment of dry eye disease by the non-ophthalmologist.

Gary N Foulks1.   

Abstract

Physicians caring for patients who have Sjögren's syndrome often face a particularly difficult task in managing the dry eye that occurs with this disease. The discomfort produced by the condition and the fluctuation of vision attendant to tear film instability are often the most annoying of the clinical symptoms. The understanding of dry eye disease in both its clinical expression and underlying etiopathology has expanded over the past 10 years with implications for management and therapy. The array of potential treatments both topical and systemic has evolved to provide a much more targeted and effective arsenal from which the clinician may choose.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984417     DOI: 10.1016/j.rdc.2008.08.008

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  6 in total

1.  Systane lubricant eye drops in the management of ocular dryness.

Authors:  Umberto Benelli
Journal:  Clin Ophthalmol       Date:  2011-06-10

2.  Endoscopic dacryocystorhinostomy as treatment for lower lacrimal pathway obstructions in adults: Review article.

Authors:  Elina Penttilä; Grigori Smirnov; Henri Tuomilehto; Kai Kaarniranta; Juha Seppä
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

3.  Eye disorders in old people.

Authors:  Mohammad Khalaj; Ameneh Barikani; Hafez Ghasemi
Journal:  Glob J Health Sci       Date:  2012-11-06

4.  Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program.

Authors:  Pierre-Jean Pisella; Marc Labetoulle; Serge Doan; Beatrice Cochener-Lamard; Mourad Amrane; Dahlia Ismail; Catherine Creuzot-Garcher; Christophe Baudouin
Journal:  Clin Ophthalmol       Date:  2018-02-05

5.  Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies.

Authors:  Andrea Leonardi; Elisabeth M Messmer; Marc Labetoulle; Mourad Amrane; Jean-Sébastien Garrigue; Dahlia Ismail; Maite Sainz-de-la-Maza; Francisco C Figueiredo; Christophe Baudouin
Journal:  Br J Ophthalmol       Date:  2018-03-15       Impact factor: 4.638

Review 6.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.